Pacific Edge Limited (PFGTF)
OTCMKTS · Delayed Price · Currency is USD
0.0986
+0.0767 (350.23%)
At close: Jul 29, 2025
Pacific Edge Revenue
In the fiscal year ending March 31, 2025, Pacific Edge had annual revenue of 22.75M NZD, down -9.83%. Pacific Edge had revenue of 11.41M in the half year ending March 31, 2025, a decrease of -1.38%.
Revenue
22.75M NZD
Revenue Growth
-9.83%
P/S Ratio
8.75
Revenue / Employee
199.55K NZD
Employees
114
Market Cap
112.78M USD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 22.75M | -2.48M | -9.83% |
| Mar 31, 2024 | 25.23M | 4.20M | 19.95% |
| Mar 31, 2023 | 21.03M | 7.90M | 60.12% |
| Mar 31, 2022 | 13.14M | 4.16M | 46.36% |
| Mar 31, 2021 | 8.98M | 4.04M | 81.72% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Pacific Edge News
- 11 months ago - Half Year 2025 Pacific Edge Ltd Earnings Call Transcript - GuruFocus